ASEAN Health Screening Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

ASEAN Health Screening Market Size

• The ASEAN health screening market size was valued at USD 20.08 billion in 2024 and is expected to reach USD 55.31 billion by 2032, at a CAGR of 13.50% during the forecast period
• The market growth is largely fueled by the growing awareness of preventive healthcare and the technological advancements in diagnostic tools, leading to increased digitalization of health services across both public and private sectors in ASEAN countries
• Furthermore, rising consumer demand for timely, accessible, and personalized health evaluations is establishing health screening services as a cornerstone of modern healthcare systems. These converging factors are accelerating the uptake of ASEAN Health Screening solutions, thereby significantly boosting the industry's growth

ASEAN Health Screening Market Analysis

• Health screening services—including routine, preventive, and specialized diagnostic packages—are increasingly vital across both public and private healthcare systems in ASEAN countries due to rising chronic disease prevalence and awareness of preventive care
• Demand is primarily driven by growing health consciousness, higher disposable incomes, expansion of diagnostic chains, and increased government-led health screening initiatives across the region
• Indonesia dominated the ASEAN health screening market with the largest revenue share of 29.7% in 2024, owing to its large population base, growing public and private healthcare infrastructure, and increasing government initiatives promoting preventive healthcare and early disease detection. Rising awareness campaigns and mandatory health checks in employment and education sectors have further fueled market growth
• Vietnam is projected to be the fastest-growing country in the ASEAN health screening market, expected to register a CAGR of 10.8% from 2025 to 2032. This growth is driven by improved access to diagnostic services in rural areas, rising disposable incomes, and a national focus on strengthening primary healthcare systems, including expanded health screening coverage under government insurance schemes
• The domestic user segment dominated the ASEAN health screening market with a market share of 73.2% in 2024, reflecting the growing emphasis on personal health monitoring and lifestyle disease prevention

Report Scope and ASEAN Health Screening Market Segmentation   

ASEAN Health Screening Market Trends

Increased Digital Integration and Convenience in Health Screening

• The growing digitization of healthcare services in ASEAN countries is enabling faster, more accessible, and cost-efficient health screening through online booking systems, mobile health apps, and digital reporting
• Increased emphasis on personalized healthcare is driving demand for screening programs tailored to genetic predispositions, lifestyle factors, and age-specific risks
• The use of portable diagnostic devices and point-of-care testing kits is expanding access to screenings in remote and rural areas where hospitals and labs are limited
• Public-private partnerships (PPPs) are being formed to build modern diagnostic infrastructure, particularly in Indonesia, Vietnam, and the Philippines
• Multiparameter screening packages covering cancer, cardiovascular, diabetes, and metabolic disorders are being bundled by hospitals and diagnostic labs to attract health-conscious consumers.
• Healthcare startups in ASEAN are offering subscription-based preventive care plans, which include periodic screenings, consultations, and telemedicine follow-ups
• Employers are increasingly integrating annual screening programs into employee wellness benefits, contributing to market growth in the corporate sector

ASEAN Health Screening Market Dynamics

Driver

Rising Demand Driven by Health Awareness and Preventive Care Initiatives

• Rising prevalence of non-communicable diseases (NCDs) like diabetes, hypertension, cardiovascular diseases, and cancer is significantly driving demand for early detection through regular screenings.
• Aging population across ASEAN, particularly in Singapore, Thailand, and Malaysia, is increasing the need for routine health monitoring and preventive diagnostics.
• Governments are launching public awareness campaigns, such as Thailand’s “Check-Up for Life” and Singapore’s “Screen for Life,” to promote early diagnosis and reduce long-term treatment costs.
• Urbanization and sedentary lifestyles are contributing to higher lifestyle-related disease risks, compelling individuals to undergo preventive screenings.
• Growth of private health insurance and employer-provided health coverage is making preventive screenings more affordable and accessible.
• Mobile health screening vans and pop-up diagnostic centers are increasing penetration in semi-urban and underserved regions.
• The COVID-19 pandemic accelerated public interest in routine check-ups and strengthened infrastructure for infectious disease screening, now being adapted for other illnesses.

Restraint/Challenge

Limited Access in Remote Areas and High Costs of Comprehensive Screening

• Despite growing interest in preventive care, unequal access remains a major hurdle across the ASEAN region. Remote and rural populations often face difficulties in accessing even basic health screening services due to a shortage of diagnostic infrastructure and trained personnel
• Advanced or specialized screenings, such as those for cancer markers, full-body imaging, or cardiovascular profiling, can be expensive and unaffordable for many, especially in lower-income countries like Cambodia, Laos, or Myanmar
• Inconsistencies in healthcare data systems and poor digital connectivity in some areas further hinder the effective delivery of screening services
• There is also a need for better public-private collaboration to ensure outreach and affordability, including mobile screening units, insurance-backed programs, and subsidized diagnostics for underserved communities
• Overcoming these challenges will require investments in infrastructure, digital access, and policy reforms, enabling equitable and widespread health screening adoption across the ASEAN bloc

ASEAN Health Screening Market Scope

The market is segmented on the basis of test type, application, panel type, care/facility, user, customer income, provider.

• By Test Type

On the basis of test type, the ASEAN Health Screening market is segmented into cholesterol tests, diabetes test, cancer tests, general check-up test, STD’s, blood pressure test, and others. The cholesterol tests segment dominated the largest market revenue share of 32.4% in 2024, driven by increasing cases of cardiovascular disease and rising awareness regarding preventive care. The simplicity, affordability, and availability of cholesterol screenings make them highly accessible across the ASEAN region.

The cancer tests segment is anticipated to witness the fastest growth rate of 22.8% from 2025 to 2032, driven by government initiatives to promote early detection and a rise in the number of screening programs offered by hospitals and diagnostic centers.

• By Application

On the basis of application, the ASEAN health screening market is segmented into cardiovascular disease, metabolic disorders, oncology, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-C complications, immunology-related conditions, and others. The cardiovascular disease segment accounted for the largest revenue share of 29.7% in 2024, owing to the increasing prevalence of heart-related illnesses and rising focus on early intervention and lifestyle management.

The oncology segment is projected to grow at the fastest CAGR of 24.1% during the forecast period due to growing cancer incidences, greater awareness, and advancements in diagnostic technologies supporting early-stage cancer detection.

• By Panel Type

On the basis of panel type, the ASEAN health screening market is segmented into multi-test panels and single-test panels. The multi-test panels segment dominated the largest market revenue share of 61.5% in 2024, due to their cost-effectiveness, bundled services, and growing demand for complete health check-up packages.

The single-test panels segment is expected to witness the fastest CAGR of 19.3% from 2025 to 2032, as consumers increasingly seek personalized or condition-specific diagnostics such as STDs or diabetes.

• By Care/Facility

On the basis of care/facility, the ASEAN health screening market is segmented into integrated and standalone. The integrated care segment held the largest revenue share of 57.6% in 2024, driven by hospital-attached screening units offering streamlined services under a single umbrella.

The standalone segment is projected to grow at the fastest CAGR of 18.9%, supported by the rapid expansion of private diagnostic centers and their convenience for walk-in customers.

• By User

On the basis of user, the ASEAN health screening market is segmented into domestic user and medical tourist. The domestic user segment dominated the largest market share of 73.2% in 2024, reflecting the growing emphasis on personal health monitoring and lifestyle disease prevention.

The medical tourist segment is expected to witness the fastest CAGR of 26.7% from 2025 to 2032, driven by the rising number of patients from other regions seeking affordable and quality diagnostics in ASEAN countries like Thailand, Singapore, and Malaysia.

• By Customer Income

On the basis of customer income, the ASEAN health screening market is segmented into upper class, medium class, and lower class. The medium class segment accounted for the largest revenue share of 48.3% in 2024, due to an expanding middle-income group prioritizing preventive healthcare.

The upper class segment is anticipated to register the fastest CAGR of 20.2%, as affluent individuals increasingly demand premium wellness and personalized screening services.

• By Provider

On the basis of provider, the ASEAN health screening market is segmented into hospitals, clinics, nursing facilities, rehabilitation centers, diagnostic laboratories, and others. The hospitals segment captured the largest revenue share of 37.6% in 2024, backed by their trustworthiness, broad infrastructure, and access to specialized medical professionals.

The diagnostic laboratories segment is projected to witness the fastest CAGR of 21.6%, owing to innovation in lab testing technologies, digital reporting, and the convenience of online booking and home collection services.

ASEAN Health Screening Market Regional Analysis

• The Asia-Pacific ASEAN health screening market is poised to grow at the fastest CAGR of 12.7% during the forecast period of 2025 to 2032, driven by increasing urbanization, rising disposable incomes, and technological advancements in countries such as China, Japan, and India
• The region's growing inclination towards preventive healthcare, supported by government initiatives promoting health awareness and digital health platforms, is driving the adoption of advanced health screening solutions
• Furthermore, as APAC emerges as a manufacturing and service hub for ASEAN Health Screening components and services, the affordability and accessibility of health screening tests are expanding to a wider consumer base

Indonesia ASEAN Health Screening Market Insight

The Indonesia ASEAN health screening market dominated the ASEAN Health Screening market with a 29.7% revenue share in 2024, driven by its large population, expanding healthcare infrastructure, and government-led awareness programs promoting early detection and preventive health checkups. Mandatory medical screenings for employment and education are also supporting market growth.

Vietnam ASEAN Health Screening Market Insight

The Vietnam ASEAN health screening market is projected to be the fastest-growing country in the ASEAN Health Screening market, expected to register a CAGR of 10.8% during 2025–2032, fueled by improved diagnostic access in rural regions, rising disposable incomes, and government efforts to expand coverage of national health screening programs through public insurance schemes.

ASEAN Health Screening Market Share

The ASEAN health screening industry is primarily led by well-established companies, including:

• Fullerton Health Corporation Limited (Singapore)
• Mount Alvernia Hospital (Singapore)
• PT Prodia Widyahusada Tbk (Indonesia)
• Raffles Medical Group (Singapore)
• Icon Group (Australia)
• Bangkok Dusit Medical Services (Thailand)
• KPJ Healthcare Berhad (Malaysia)
• Mahkota Medical Centre (Malaysia)
• Siloam International Hospitals (Indonesia)
• Healthway Medical Group (Singapore)
• Thonburi Healthcare Group (Thailand)
• Parkway Pantai (Malaysia)

Latest Developments in ASEAN Health Screening Market

• In August 2022, Fullerton Health Corporation Limited announced that it had completed a merger led by RRJ Capital (“RRJ”) involving an equity injection by the private equity firm and a senior loan totalling USD 390 million. The merger delivered a stronger balance sheet and a new capital structure which propelled the post-pandemic growth opportunities for the pan-Asian healthcare provider
• In April 2023, Siemens Healthineers expanded its footprint in Southeast Asia by launching a comprehensive health screening solution tailored for urban hospitals and clinics across Singapore and Malaysia. This initiative includes advanced imaging technologies and AI-powered diagnostic tools aimed at improving early detection of chronic diseases. Siemens emphasizes partnerships with regional healthcare providers to improve accessibility and reduce screening turnaround times
• In March 2023, Philips Healthcare introduced a mobile health screening van program in Indonesia and the Philippines to reach underserved populations. Equipped with portable ultrasound and blood testing devices, the initiative aims to boost preventive care by providing routine health checks and early diagnosis of cardiovascular diseases and diabetes in rural communities. Philips reported that these mobile units helped increase health screening rates by over 20% in pilot areas
• In February 2023, Fujifilm Healthcare partnered with Thailand’s Ministry of Public Health to deploy digital radiography and automated health screening kiosks in public hospitals. The project supports the government's “Screen for Life” program to enhance early cancer detection and reduce healthcare disparities. Fujifilm's technology enables faster image processing and remote specialist consultations, improving patient outcomes
• In January 2023, Roche Diagnostics launched its enhanced cardiovascular risk screening test kits across ASEAN countries, including Vietnam and Cambodia. The kits feature simplified sample collection and quicker lab processing, enabling broader adoption by smaller clinics and diagnostic centers. Roche highlighted that this move supports rising demand for early detection tools amidst increasing cardiovascular disease incidence in the region
• In January 2023, GE Healthcare introduced AI-enabled mammography solutions to multiple healthcare facilities in Malaysia and Singapore, improving breast cancer screening accuracy and efficiency. The system integrates machine learning algorithms to assist radiologists in identifying early-stage abnormalities, promising to reduce diagnostic errors and enhance patient care

SKU-72693